Tobacco giant Philip Morris International (PMI) has bought a 22.61 percent stake in British asthma inhaler maker Vectura. Following the deal, PMI announced that it plans to continue acquiring Vectura shares on the market at 165p (RUB167) per share. informs CNBC.
PMI is interested in Vectura, as it believes that in the future, the acquisition of the company will allow it to earn more. The cigarette maker is counting on the absorption of Vectura, intending increase their revenues from the sale of goods and services not related to nicotine, up to a billion dollars a year. It is assumed that PMI will gain access to inhaler technologies for the production of alternative smoking systems, however, the production of the asthma drugs Vectura will continue after the takeover.
Read Also
- Google Artificial Intelligence creates super-realistic images with just a text description May 25, 2022
- What is the threat of the Islamic State in Afghanistan? Aug 26, 2021
- Mohamed VI expresses his intention to open a “new stage” with Spain Aug 20, 2021
- Dragon Ball Super: this XL Super Saiyan Vegeta Blue collector figurine is canon May 29, 2022
- Ricciardo: “I’ve always believed in it” | FormulaPassion.it Sep 15, 2021
- Gamma registers sustained growth in the first quarter | News | Communications May 31, 2021
- Comptroller’s Office prohibits the Municipality of Paillaco from continuing to issue gas vouchers Nov 17, 2022